Daniel A. Valenti

Valenti-JRS_0013HDan Valenti joined PathGroup in 2013 as Senior Vice President and Chief Information Officer. He has served in a similar capacity for a diverse group of both Fortune 100 companies and startups in a number of industry segments including healthcare, banking, brokerage, energy and utilities. Prior to joining PathGroup, Mr. Valenti was the Chief Information Officer for Ameritox, Ltd., where he led the IT organization in the development of a Laboratory Management Information System and multiple customer-facing and mobile applications. This included the management and oversight of Business Intelligence and Security, and development of the company’s Customer Engagement Center. In addition to his years of experience leading IT teams, Mr. Valenti has a JD and MBA and has worked as an attorney and consultant.

2009 Archive

ANA Interpretive Chart

BD Affirm VPIII Vaginitis/Vaginosis Panel Test Update February 2009

BD Affirm VPIII Vaginitis/Vaginosis Panel Test Update

Testing Provided on Site for ANA Screen

Change in Allergen Classification System

Testing Provided on Site for Anti-Cardiolipin IgG, IgM, & IgA

Testing Provided on Site for Antistreptolysin-O

Elimination of Testing for the Weak Expression of the D Antigen

Testing Provided on Site for Antistreptolysin-O

Testing Provided on Site for CMV IgG

Testing Provided on Site for CMV IgM

Methodology Change for Epstein-Barr Virus Testing

Cervical DNA DTex Technical Update

Free Testosterone Profiles Test Update

Reporting Pediatric Range Change for Fasting Glucose

Methodology Change for H. pylori Qualitative Assay

Test Revision: Group B Streptococcus by PCRTesting Provided on Site for H. pylori IgA and IgG

Testing Provided on Site for Toxoplasma IgG and IgM

Reporting Change for Hepatitis B Surface Total Antibodies

Reporting Change for Hepatitis B Surface Total Antibodies

Reporting of Average Glucose with Hemoglobin A1c

Technical Update: HCV Genotyping now referred to ARUP

Technical Update: Hepatitis C Quantitative Viral Load now FDA-Cleared

KRAS Mutation Detection in Colorectal Carcinoma Test Update

Methodology Change for Herpes Simplex Virus Types 1 & 2 IgG Testing

Update for Maternal Screen Testing

Testing Provided on Site for Measles (Rubeola) IgG

Testing Provided on Site for Mumps IgG

Testing provided on site for PLAC® Test (Lp-PLA2)

Reporting of Non-HDL Cholesterol

Resulting EMR Accounts Update

New Assay: Respiratory Virus Panel by PCR

Stool Collecting and Handling Instructions

Stool Spreadsheet July 2009

Discontinued: Syphilis Screen IgG w/Reflex to FTA

Methodology Change for Syphilis Screen IgG

Methodology Change: Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Detection

Syphilis Testing Algorithm

Syphilis Interpretation Chart

Testing Provided on Site for ToRC IgG

Testing Provided on Site for ToRC IgG – Revised

Reporting Pediatric Range Change for Total Cholesterol

Toxoplasma IgG/IgM Ordering Correction

Testing Provided on Site for Toxoplasma IgG and IgM

Testing provided on Site for Urea Breath Test for H. pylori

Toxoplasma IgG / IgM Ordering Correction

Testing Provided on Site for Toxoplasma IgG and IgM

Urovysion – Bladder Cancer Molecular Detection Test Update

CPT Code Change for Urine Drug Screen

Testing Provided on Site for Anti-MPO, Anti-PR3, Anti-GBM

BD Affirm VPIII Vaginitis/Vaginosis Panel Test Update

 

Why PathGroup Oncology

pathgroup-WhyPathGroupOncology

PathGroup is privately held and physician-centric. Our staff is made up of more than 75 board-certified pathologists with a dedicated team of hematopathologists. PathGroup can provide physicians and their patients with comprehensive oncology diagnostic and clinical services that are accurate, fast, and personalized — most covered by contractual relationships with major insurance providers.

All of our services are directed from a single point of contact and are anchored by industry-leading turnaround times that enable timely patient management and therapeutic intervention. We are committed to bringing advanced genomic profiling to our clients with the most current data and bioinformatics tools, concise reporting and deep expertise.

Our medical staff and physician leadership is comprised of individuals in every pathology specialty and subspecialty, as well as fellowship training in:

  • Oncologic Pathology
  • Oncologic Surgical Pathology
  • Molecular Pathology
  • Neuropathology
  • Gynecologic Pathology
  • Breast Pathology
  • Renal/Hepatobilliary/Gastrointestinal/ Pancreatic Pathology
  • Bone And Soft Tissue Pathology

PathGroup’s relationship with GenoSpace provides access to all the information and tools you need to take full advantage of advanced genomic medicine. GenoSpace integrates new and existing clinical, laboratory, genomic, and other health information within customized portals for physicians and their patients. And through GenoSpace’s partnership with Thomson Reuters, the most recent information on genomic variants and their clinical indications are also integrated into our data. Together with these partners, PathGroup delivers the most clinically relevant and actionable information without ever overwhelming providers with data—bringing advanced precision and true personalized medicine to clinical care.

Scott Jeffers

Jeffers-fullScott Jeffers joined PathGroup as Executive Vice President and Chief Operating Officer in 2023. He brings 30 years of operational leadership experience, with over two decades of leading operations across Fortune 500 companies and is a veteran in the healthcare space. Scott joined PathGroup from 3M, where he was Senior Vice President, Global Supply Chain and Lean Six Sigma responsible for end-to-end operations strategy and continuous improvement. Prior to 3M, Scott was the head of Enterprise Operations at Quest Diagnostics where he led the Operational Excellence strategies across Patient Services, Logistics, Lab Operations, Customer Service, Global Procurement and Revenue Cycle Management with a significant focus on digital transformation. Scott also spent over 16 years in the MedTech industry where he was the Chief Supply Chain Officer at Hill-Rom, now part of Baxter, and held multiple executive positions of increasing responsibility at GE Healthcare. Early in his career, Scott was an Officer in the United States Air Force, serving in both operational and R&D roles.

The PathGroup Advantage

PathGroup is leading the industry in precision medicine with a dedicated team of scientists and 80 experienced board-certified pathologists representing every subspecialty. Our team is dedicated to provide solutions to optimize your clinical trial.

Partnering with us adds value to your programs through a collaborative approach to providing scientific insight and tailored solutions led by recognized experts in academia, industry agencies and regulatory entities. We provide active collaboration on many peer-reviewed publications, leadership roles within CAP, AMP, ASHG and CGCC, and ongoing education through webinars and internships.

Our strategic relationships include an extensive network of community-based clinicians and their patients. The medical community looks to PathGroup’s scientific team for guidance, leadership and education in the ever-changing healthcare landscape. Our technology partners in clinical and molecular diagnostics rely on PathGroup to help create cutting-edge technology and bioinformatics solutions. We strive to continually provide quality-driven, responsive partnerships.

PathGroup is one of the largest privately owned pathology groups in the United States.

Contact us to schedule time to discuss your project:

biopharma@pathgroup.com
615-221-4455

Pranil K. Chandra, DO, FCAP, FASCP

Chandra-HRMedical School: New York College of Osteopathic Medicine
Residency: New York University Langone Medical Center
Board Certification: Anatomic Pathology, Clinical Pathology, Hematopathology, Molecular Genetic Pathology
Fellowship Training: Oncologic Surgical and Molecular Genetic Pathology- MD Anderson Cancer Center

Fellowship Training: Hematopathology – NYU Langone Medical Center
Specialty: Molecular Pathology
Location: Nashville, TN
Phone:  615-234-56610
Email: pchandra@pathgroup.com

 

Dr. Chandra joined PathGroup in 2011 as Associate Medical Director of Molecular Pathology and now currently serves as Senior Vice President and Chief Genomics Officer at PathGroup. Dr. Chandra holds board certifications in anatomic and clinical pathology, hematopathology and molecular genetic pathology. He completed his AP/CP training and fellowships in hematopathology, oncologic pathology and molecular pathology at NYU Langone Medical Center and the University of Texas-MD Anderson Cancer Center, respectively. While at MD Anderson, he served as Chief Fellow and received numerous awards for his research in acute myeloid leukemia. He has presented numerous abstracts and platform presentations at various pathology meetings and has published peer-reviewed articles and book chapters. Dr. Chandra is a member of the American Society of Clinical Pathology, College of American Pathologists, and Association of Molecular Pathology where he also serves in a leadership capacity to the Economic Affairs Committee as Vice-Chair of Coverage. Dr. Chandra is a recognized medical consultant in molecular pathology and personalized medicine and is considered a national thought leader in Precision Medicine and Cancer Genomics.

Hospital Services

PathGroup’s Hospital Services Model: Physician-Centered and Patient-Focused

In today’s rapidly changing healthcare environment, it is increasingly important to provide healthcare services that improve the quality of patient care and reduce healthcare costs, all while enhancing physician and patient satisfaction.  Whether you are looking for professional pathology services for your facility, or are considering fully outsourcing your pathology lab, PathGroup may be the missing piece to your strategy.

PathGroup was started in 1965 as a hospital based pathology group, and has grown to be a leading provider of comprehensive pathology services.  We currently serve as the pathology provider for more than 70 hospitals and thousands of physician groups and surgery centers.

Why PathGroup?

  • Reduced Administrative Burden – PathGroup is the only pathology services company in the industry offering turn-key solutions for hospitals seeking pathologist coverage.
  • Continuum of Care for Patients — With a breadth of pathology services, PathGroup offers lab solutions for Anatomic Pathology, Clinical Pathology, Molecular Diagnostics and Esoteric/Specialty Pathology services, eliminating the need to coordinate multiple reference labs, and enhancing the continuum of care for patients.
  • Expanded Expertise for Complex Cases—PathGroup’s more than 70 pathologists represent every pathology sub-specialty, providing additional consultation with no increased cost.  Our depth of expertise is a result of our pathologists acquiring subspecialty training and/or certification in all areas of pathology.
  • Enhanced Physician Satisfaction—PathGroup is majority-owned and operated by pathologists, resulting in a hospital services model that is physician-centric.
  • Enhanced Patient Satisfaction—PathGroup leads the industry when it comes to turnaround time.  For most services, we provide diagnostic results the next day, which is unprecedented in the anatomic testing arena and is a key factor to enhanced patient satisfaction.
  • Improved Patient Outcomes – With access to PathGroup’s Molecular Diagnostics, we provide oncologists and hematologists with clinically-actionable diagnoses specific to the individual patient, saving precious time for patients with life-threatening illnesses, and improving patient outcomes that enhance the patient’s quality of life.
  • Robust Information Technology Services—With the creation of Accountable  Care Organizations (ACOs) and continued healthcare reform on the horizon, a robust IT partner is extremely important to the future success of healthcare organizations. PathGroup’s IT team has implemented over 425 EHR/EMR interfaces with healthcare partners, providing physicians with expedient electronic access to patient results.
  • Mirroring the Hospital’s Managed Care Contracts—With over 100 Managed Care contracts, our goal is to ensure that we are in-network with the same providers as your hospital system.
  • Quality Assurance/Quality Control (QA/QC)—PathGroup’s extensive and comprehensive QA/QC program ensures consistent quality throughout the organization. For hospital clients who decide to deploy PathGroup’s proprietary “PathSys LIS” system, PathGroup has the ability to implement an automated QA/QC audit and review process which features on-demand QA/QC reporting capabilities.

Strong partnerships are increasingly important to succeed in this era of healthcare reform. Learn more about how a pathology partnership with PathGroup could benefit your hospital or system.

For more information on how a PathGroup partnership can benefit you, contact:

Randy Sanderson, Vice President of Business Development
Phone: 615-221-4436
rsanderson@pathgroup.com

 


If you are a Pathologist, Pathology Group or hospital interested in partnering with PathGroup, please submit the following information and a PathGroup representative will be in touch with you.

First Name (required)

Last Name (required)

Hospital or Pathology Practice Name (required)

Your Job Title (required)

City/State (required)

Email Address (required)

Phone Number (required)

How Did You Hear About Us? (required)

Comments (required)

I am interested in? (required)

Urology

PathGroup clients rely on our dedicated Urologic Pathology team to interpret and deliver accurate, timely results for the best possible patient care. Combined with the doctor’s knowledge of a patient’s medical history, PathGroup’s team of specialists provides the most comprehensive diagnostic information from which to determine a course of treatment. Our quality, focused reporting provides definitive diagnoses, reducing the frustration and additional testing that comes with equivocal diagnoses.

PathGroup’s comprehensive Urologic Pathology services include:

  • Prostate, Bladder, Ureter and Urethral Anatomic Pathology
  • DNA Ploidy Analysis
  • Immunohistochemical Analysis
  • UroVysion (FISH)
  • Urine Cytology
  • PCA3
  • Total PSA and Free/Total Ratio PSA
  • Stone Analysis (Chemical Composition)
  • Additional, full-service clinical lab testing from a single source

From a prostate biopsy, our team can deliver all AJCC/CAP required diagnostic parameters, including:

  • Combined Gleason Score (prognostic)
  • Percent tissue involvement
  • Number of cores involved
  • Capsular penetration
  • Perineural invasion
  • Spatial location/Tumor quantitation
  • Seminal vesicle involvement
  • Margin assessment

Why PathGroup?

Our physician-centric, patient focused approach has made PathGroup an industry leader and trusted partner for quality patient care.

  • More than 30,000 Urology specimens diagnosed each year
  • Dedicated Urologic Pathology team
  • Robust Quality Assurance Program, with 5% of cases reviewed retrospectively by a second pathologist, and the ability to increase this percentage if desired
  • On-site subspecialty pathology teams providing consultation when necessary at no additional charge
  • Industry leading turnaround times and responsive customer service
  • Clear, concise reporting including color images and mapping, with photomicrographs included in abnormal or unusual cases
  • Innovative technology solutions, including iPad, iPhone and web-based applications
  • Full range of additional clinical and molecular laboratory services for comprehensive service from a single source

 

Careers

In order to provide the highest level of service and care to our clients, physicians, employees, payers, and most importantly, our patients, PathGroup is continuously seeking quality individuals who share our values. If you are enthusiastic, have initiative, good character, interpersonal skills, a willingness to assume responsibility, and would like to be part of the PathGroup team, please visit our Careers page for all available opportunities.

We offer excellent benefits including medical, dental, life insurance, LTD, and 401(k). Please feel free to submit cover letter and résumé. Please state the position for which you are applying and mail or fax to:

Human Resources Department
5301 Virginia Way, Suite 300
Brentwood, TN 37027
Fax: 615.234.2502
Email: hr@pathgroup.com

Check back frequently as we will post any new openings as they become available.

PathGroup does not discriminate in employment decisions on the basis of race, color, sex, religion, national origin, age or disability.

PathSupply

PathSupply, PathGroup’s online supply ordering system, gives our clients the ability to order clinical supplies, search products, review purchase history and status updates from one centralized location. Offering a wide range of products related to all of PathGroup’s services, the PathSupply online site also provides image-guided reference for each supply. We understand our clients’ need for fast and efficient service. With the assistance of our vast courier network and strategically placed hubs throughout the region, PathSupply delivers industry-leading turnaround times.

Click here to access PathSupply online.